Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer.
第一作者:
Jiliang,Zhang
第一单位:
Department of Radiology, Fuwai Central China Cardiovascular Hospital, #1 Fuwai Road, Zhengzhou, Henan Province, 450000, China.
作者:
主题词
乙酰胺类(Acetamides);动物(Animals);细胞凋亡(Apoptosis);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);综合疗法(Combined Modality Therapy);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);吲哚类(Indoles);小鼠(Mice);肿瘤复发, 局部(Neoplasm Recurrence, Local);苯乙醚类(Phenyl Ethers);光化学疗法(Photochemotherapy);光敏感药(Photosensitizing Agents);生活质量(Quality of Life);受体, 大麻酚, CB2(Receptor, Cannabinoid, CB2);受体, GABA(Receptors, GABA);单态氧(Singlet Oxygen);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1016/j.pdpdt.2018.09.006
PMID
30240926
发布时间
2019-12-01
- 浏览8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文